Search Results - "MATHESON, Della"

Glucose and C-Peptide Changes in the Perionset Period of Type 1 Diabetes in the Diabetes Prevention Trial-Type 1 by Sosenko, Jay M, Palmer, Jerry P, Rafkin-Mervis, Lisa, Krischer, Jeffrey P, Cuthbertson, David, Matheson, Della, Skyler, Jay S

“…OBJECTIVE:--We examined metabolic changes in the period immediately after the diagnosis of type 1 diabetes and in the period leading up to its diagnosis in…”
Get full text

Supporting Persons Living With Type 1 Diabetes during Hurricanes by Ponder, Stephen W., Atkinson, Carol, Imber, Anne, Jordán, Carlos Alberto Leyva, Matheson, Della Lorraine, Dimentstein, Karen, Espinel, Zelde, Shultz, James m.

“…As climate change alters the hazard properties of Atlantic hurricanes, persons with type 1 diabetes (T1D) who live along the US hurricane coast and in the…”
Get full text

Is There a Place for Insulin Pump Therapy in Your Practice? by Skyler, Jay S., Ponder, Steven, Kruger, Davida F., Matheson, Della, Parkin, Christopher G.

“…Is There a Place for Insulin Pump Therapy in Your Practice? Jay S. Skyler , MD, MACP , Steven Ponder , MD, FAAP, CDE , Davida F. Kruger , MSN, APRN-BC, BC-ADM…”
Get full text

Obesity in Youth with Type 1 Diabetes in Germany, Austria, and the United States by DuBose, Stephanie N., MPH, Hermann, Julia M., MS, Tamborlane, William V., MD, Beck, Roy W., MD, PhD, Dost, Axel, MD, DiMeglio, Linda A., MD, MPH, Schwab, Karl Otfried, MD, Holl, Reinhard W., MD, Hofer, Sabine E., MD, Maahs, David M., MD, PhD

“…Objective To examine the current extent of the obesity problem in 2 large pediatric clinical registries in the US and Europe and to examine the hypotheses that…”
Get full text

Slowed Metabolic Decline After 1 Year of Oral Insulin Treatment Among Individuals at High Risk for Type 1 Diabetes in the Diabetes Prevention Trial-Type 1 (DPT-1) and TrialNet Oral Insulin Prevention Trials by Sosenko, Jay M, Skyler, Jay S, Herold, Kevan C, Schatz, Desmond A, Haller, Michael J, Pugliese, Alberto, Cleves, Mario, Geyer, Susan, Rafkin, Lisa E, Matheson, Della, Palmer, Jerry P

“…We assessed whether oral insulin slowed metabolic decline after 1 year of treatment in individuals at high risk for type 1 diabetes. Two oral insulin trials…”
Get full text

Who Is Enrolling? The Path to Monitoring in Type 1 Diabetes TrialNet's Pathway to Prevention by Sims, Emily K, Geyer, Susan, Johnson, Suzanne Bennett, Libman, Ingrid, Jacobsen, Laura M, Boulware, David, Rafkin, Lisa E, Matheson, Della, Atkinson, Mark A, Rodriguez, Henry, Spall, Maria, Elding Larsson, Helena, Wherrett, Diane K, Greenbaum, Carla J, Krischer, Jeffrey, DiMeglio, Linda A

“…To better understand potential facilitators of individual engagement in type 1 diabetes natural history and prevention studies through analysis of enrollment…”
Get full text

A new approach for diagnosing type 1 diabetes in autoantibody-positive individuals based on prediction and natural history by Sosenko, Jay M, Skyler, Jay S, DiMeglio, Linda A, Beam, Craig A, Krischer, Jeffrey P, Greenbaum, Carla J, Boulware, David, Rafkin, Lisa E, Matheson, Della, Herold, Kevan C, Mahon, Jeffrey, Palmer, Jerry P

“…We assessed whether type 1 diabetes (T1D) can be diagnosed earlier using a new approach based on prediction and natural history in autoantibody-positive…”
Get full text

A phase 2 randomized trial with autologous polyclonal expanded regulatory T cells in children with new-onset type 1 diabetes by Bender, Christine, Wiedeman, Alice E, Hu, Alex, Ylescupidez, Alyssa, Sietsema, William K, Herold, Kevan C, Griffin, Kurt J, Gitelman, Stephen E, Long, S Alice

“…CD4 CD25 CD127 FOXP3 regulatory T cells (T ) play a key role in preventing autoimmunity. In autoimmune type 1 diabetes (T1D), adoptive transfer of autologous…”
Get more information

Acceleration of the Loss of the First-Phase Insulin Response During the Progression to Type 1 Diabetes in Diabetes Prevention Trial―Type 1 Participants by SOSENKO, Jay M, SKYLER, Jay S, BEAM, Craig A, KRISCHER, Jeffrey P, GREENBAUM, Carla J, MAHON, Jeffrey, RAFKIN, Lisa E, MATHESON, Della, HEROLD, Kevan C, PALMER, Jerry P

“…We studied the change in the first-phase insulin response (FPIR) during the progression to type 1 diabetes (T1D). Seventy-four oral insulin trial progressors…”
Get full text

Erratum. Who Is Enrolling? The Path to Monitoring in Type 1 Diabetes TrialNet's Pathway to Prevention. Diabetes Care 2019;42:2228-2236 by Sims, Emily K, Geyer, Susan, Johnson, Suzanne Bennett, Libman, Ingrid, Jacobsen, Laura M, Boulware, David, Rafkin, Lisa E, Matheson, Della, Atkinson, Mark A, Rodriguez, Henry, Spall, Maria, Larsson, Helena Elding, Wherrett, Diane K, Greenbaum, Carla J, Krischer, Jeffrey, DiMeglio, Linda A

Get full text

Use of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS) for Improving the Accuracy of the Risk Classification of Type 1 Diabetes by SOSENKO, Jay M, SKYLER, Jay S, HEROLD, Kevan C, EISENBARTH, George, PALMER, Jerry P, MAHON, Jeffrey, KRISCHER, Jeffrey P, GREENBAUM, Carla J, RAFKIN, Lisa E, BEAM, Craig A, BOULWARE, David C, MATHESON, Della, CUTHBERTSON, David

“…OBJECTIVE We studied the utility of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS) for improving the accuracy of type 1 diabetes (T1D) risk…”
Get full text

The Effect of Ethnicity in the Rate of Beta-Cell Functional Loss in the First 3 Years After Type 1 Diabetes Diagnosis by Tosur, Mustafa, Cleves, Mario A, Sosenko, Jay M, Libman, Ingrid, Baidal, David A, Balasubramanyam, Ashok, Redondo, Maria J

“…Abstract Objective We set forth to compare ethnicities for metabolic and immunological characteristics at the clinical diagnosis of type 1 diabetes (T1D) and…”
Get full text

Use of Dried Capillary Blood Sampling for Islet Autoantibody Screening in Relatives: A Feasibility Study by Bingley, Polly J, Rafkin, Lisa E, Matheson, Della, Steck, Andrea K, Yu, Liping, Henderson, Courtney, Beam, Craig A, Boulware, David C

“…Islet autoantibody testing provides the basis for assessment of risk of progression to type 1 diabetes. We set out to determine the feasibility and…”
Get more information

The development and utility of a novel scale that quantifies the glycemic progression toward type 1 diabetes over 6 months by Sosenko, Jay M, Skyler, Jay S, Beam, Craig A, Boulware, David, Mahon, Jeffrey L, Krischer, Jeffrey P, Greenbaum, Carla J, Rafkin, Lisa E, Matheson, Della, Herold, Kevan C, Palmer, Jerry P

“…We developed a scale to serve as a potential end point for 6-month glycemic progression (PS6M) toward type 1 diabetes (T1D) in autoantibody-positive relatives…”
Get full text

Decision-Making in Diabetes Mellitus Type 1 by Rustad, James K, Musselman, Dominique L, Skyler, Jay S, Matheson, Della, Delamater, Alan, Kenyon, Norma S, Cáceda, Ricardo, Nemeroff, Charles B

“…Decreased treatment adherence in patients with diabetes mellitus type 1 (type 1 DM) may reflect impairments in decision-making and underlying associated…”
Get full text

Immune profiling by multiple gene expression analysis in patients at-risk and with type 1 diabetes by Han, Dongmei, Leyva, Carlos A, Matheson, Della, Mineo, Davide, Messinger, Shari, Blomberg, Bonnie B, Hernandez, Ana, Meneghini, Luigi F, Allende, Gloria, Skyler, Jay S, Alejandro, Rodolfo, Pugliese, Alberto, Kenyon, Norma S

“…Abstract There is a need for biomarkers to monitor the development and progression of type 1 DM. We analyzed mRNA expression levels for granzyme B, perforin,…”
Get full text

Increased Proportions of Circulating Proins^sup +^ Peripheral Antigen Expressing (PAE) Cells in Type 1 Diabetes by Garcia, Carlos, Allende, Gloria, Matheson, Della, Marks, Jennifer

Get full text

Unexplained Hyperglycemia in Continuous Subcutaneous Insulin Infusion: Evaluation and Treatment by Ponder, Stephen W, Skyler, Jay S, Kruger, Davida F, Matheson, Della, Brown, Bruce W

“…Purpose The purpose of this review study was to determine and categorize commoncauses of intermittent hyperglycemia and suggest potential measures to…”
Get full text

Unexplained Hyperglycemia in Continuous Subcutaneous Insulin Infusion by Ponder, Stephen W., Skyler, Jay S., Kruger, Davida F., Matheson, Della, Brown, Bruce W.

“…Purpose The purpose of this review study was to determine and categorize common causes of intermittent hyperglycemia and suggest potential measures to prevent…”
Get full text

Diabetes and pregnancy: need and use of intensive therapy by Matheson, D, Efantis, J

“…This paper explains the physiology of pregnancy and interrelates this information with the effects of pregnancy on the woman with pregestational diabetes…”
Get more information